Bill & Melinda Gates Foundation - Q1 2022 holdings

$186 Million is the total value of Bill & Melinda Gates Foundation's 11 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
VIR BuyVIR BIOTECHNOLOGY INC$40,100,000
+41.2%
1,559,142
+130.0%
21.56%
+150.2%
BuySERA PROGNOSTICS INC$3,000,000
-44.4%
799,814
+2.6%
1.61%
-1.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CUREVAC N V12Q3 202358.0%
VIR BIOTECHNOLOGY INC12Q3 202332.0%
BIONTECH SE12Q3 202335.8%
ATRECA INC12Q3 20235.3%
AMYRIS INC12Q3 20231.2%
IMMUNCORE HLDGS PLC11Q3 202335.7%
BUTTERFLY NETWORK INC11Q3 20233.8%
LUMIRADX LTD8Q3 202318.0%
EXSCIENTIA8Q3 202313.3%
ZYMERGEN INC6Q3 20220.3%

View Bill & Melinda Gates Foundation's complete holdings history.

Latest significant ownerships (13-D/G)
Bill & Melinda Gates Foundation Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
LumiraDx LtdAugust 03, 202219,859,77315.8%
Atreca, Inc.February 16, 20211,396,6444.7%
Liquidia Technologies IncFebruary 12, 2020119,6780.5%
X4 Pharmaceuticals, IncMarch 15, 2019120,3631.8%
Arsanis, Inc.February 13, 2018722,1795.1%

View Bill & Melinda Gates Foundation's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
SC 13D2022-08-03
SC 13G2022-07-15

View Bill & Melinda Gates Foundation's complete filings history.

Compare quarters

Export Bill & Melinda Gates Foundation's holdings